from Reuters: Health News https://ift.tt/2Tqqdax
Sunday, March 24, 2019
Sunday, March 24, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Johnson & Johnson on Thursday said it will record a nearly $700 million impairment charge in the first quarter of 2019 related to the abandoned development of its experimental antiviral drug, AL-8176.

from Reuters: Health News https://ift.tt/2Tqqdax
from Reuters: Health News https://ift.tt/2Tqqdax
Related Posts:
LATEST HEALTH NEWS(Reuters Health) - Teens with painful chronic illnesses may find that YouTube can provide a support network, a new study suggests. from Reuters: Health News https://reut.rs/2WgYewj … Read More
LATEST HEALTH NEWS(Reuters Health) - People are less likely to take their heart medicine when their local pharmacies close, and the drop-off persists for at least a year, according to a U.S. study. from Reuters: Health News https://reut.r… Read More
LATEST HEALTH NEWS(Reuters Health) - Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson's disease have seen steep increases in their out-of-pocket costs for drugs in recent years, a U.S. study suggests. … Read More
LATEST HEALTH NEWS(Reuters Health) - Looking online for alternative medicine providers to diagnose or treat celiac disease is a bad idea because many websites market unproven or ineffective tests and treatments, researchers say. from Reut… Read More
LATEST HEALTH NEWSMerck & Co said on Wednesday it has increased production of the measles vaccine to meet an uptick in demand in the United States in the midst of the country's biggest outbreak in 25 years. from Reuters: Health News h… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment